Radioiodine Treatment of Basedow's Disease: Interference and Influence Factors, Risk Estimation
- 1 January 1991
- journal article
- review article
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 97 (02/03) , 275-285
- https://doi.org/10.1055/s-0029-1211078
Abstract
I-131 treatment of Basedow's disease is effective and safe. Relatively high energy doses to the thyroid in the range of 150—200 Gray are needed in endemic goiter areas, where immunogenic hyperthyroidism may coincide with functional autonomy. Induction of euthyroidism by low doses of antithyroid drugs (methimazole, carbimazole) before I-131 treatment prevents complications and has no significant influence on outcome of I-131 therapy. As compared to alternative therapeutic modalities, the risks of I-131 are low.Keywords
This publication has 0 references indexed in Scilit: